Terms: = Head and neck cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Prognosis
11 results:
1. "Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.
Matošić Ž; Šimunović L; Jukić T; Granić R; Meštrović S
Prog Orthod; 2024 Mar; 25(1):12. PubMed ID: 38523193
[TBL] [Abstract] [Full Text] [Related]
2. JNK2 Promotes Progression of Esophageal Squamous Cell Carcinoma
Wang L; Guo M; Gao L; Liu K; Bai J; Liu Z
Curr Pharm Des; 2023; 29(37):2977-2987. PubMed ID: 37957865
[TBL] [Abstract] [Full Text] [Related]
3. The axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma.
An YZ; Cho E; Ling J; Zhang X
BMC Cancer; 2020 Oct; 20(1):987. PubMed ID: 33046030
[TBL] [Abstract] [Full Text] [Related]
4. Phenome-Wide Scan Finds Potential Orofacial Risk Markers for cancer.
Bezamat M; Harrison B; Zhou Y; Glickman KM; Telles V; Guirguis C; Modesto A; Vieira AR
Sci Rep; 2020 Mar; 10(1):4869. PubMed ID: 32184411
[TBL] [Abstract] [Full Text] [Related]
5. Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines.
Lepore S; Lettini G; Condelli V; Sisinni L; Piscazzi A; Simeon V; Zoppoli P; Pedicillo MC; Natalicchio MI; Pietrafesa M; Landriscina M
Int J Med Sci; 2020; 17(1):112-124. PubMed ID: 31929745
[No Abstract] [Full Text] [Related]
6. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-374a promotes esophageal cancer cell proliferation via axin2 suppression.
Wang Y; Xin H; Han Z; Sun H; Gao N; Yu H
Oncol Rep; 2015 Oct; 34(4):1988-94. PubMed ID: 26252180
[TBL] [Abstract] [Full Text] [Related]
8. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma.
Zhao Y; Liu X; Zhong L; He M; Chen S; Wang T; Ma S
Int J Mol Med; 2015 Oct; 36(4):1097-103. PubMed ID: 26252081
[TBL] [Abstract] [Full Text] [Related]
9. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer.
Stewart DJ; Chang DW; Ye Y; Spitz M; Lu C; Shu X; Wampfler JA; Marks RS; Garces YI; Yang P; Wu X
Pharmacogenomics J; 2014 Dec; 14(6):509-22. PubMed ID: 24980784
[TBL] [Abstract] [Full Text] [Related]
10. Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
Honing J; Pavlov KV; Meijer C; Smit JK; Boersma-van Ek W; Karrenbeld A; Burgerhof JG; Kruyt FA; Plukker JT
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S657-64. PubMed ID: 24833101
[TBL] [Abstract] [Full Text] [Related]
11. Frequent accumulation of nuclear E-cadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas.
Salahshor S; Naidoo R; Serra S; Shih W; Tsao MS; Chetty R; Woodgett JR
Mod Pathol; 2008 Mar; 21(3):271-81. PubMed ID: 18084253
[TBL] [Abstract] [Full Text] [Related]
